Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "standard"

1853 News Found

UICC report flags air pollution as major multi-cancer risk
Healthcare | April 20, 2026

UICC report flags air pollution as major multi-cancer risk

The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%


C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
Healthcare | April 20, 2026

C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools

Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits


GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


FDA pushes forward on gene-editing therapies with new safety roadmap
Biotech | April 20, 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases


Takara Bio and Resistomap forge deal to speed up global fight against superbugs
News | April 19, 2026

Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence


Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals
Hospitals | April 18, 2026

Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals

Move strengthens footprint in Western India and expands multi-specialty care network


NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes
Policy | April 18, 2026

NHA convenes Chintan Shivir to accelerate Ayushman Bharat schemes

Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
Supply Chain | April 18, 2026

Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem

Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy